szentecyclolabhu

June 30, 2023 Drug delivery / Pharma applications

Cyclodextrin-containing drugs among top 200 Brand Name Drugs by retail sales

A recent poster by R.E. Williams and C. M. Marshall, (Jon Njardarson’s group, University of Arizona) listed the Top 200

June 22, 2023 CD as API / Pharma applications

Serving patient’s safety and comfort: Effects of sugammadex vs. neostigmine on postoperative nausea, vomiting and pulmonary complications following general anesthesia.

A recent study published by Korean scientists compared the effect of sugammadex with that of neostigmine in terms of the

June 14, 2023 CD as API / CD derivatives / Pharma applications

A sugammadex-analogue, per-6-O-carboxyhexyl-thio-gamma-CD (OKL-1111) is a highly potent and universal reversal agent for anticoagulants

Antithrombotic therapy is undoubtedly associated with a risk for bleeding and these bleeding complications sometimes can be life-threatening. Recently, specific

April 5, 2023 Other industrial use

Cyclodextrins to control bacteriophages infection in biotechnology

In the biotechnology industry one of the biggest threats for bacteria-driven bioreactors is the infections caused by enemies of bacteria,

March 6, 2023 Drug delivery / Pharma applications

Cyclodextrin-enabled nepafenac eye drops with improved absorption

Nepafenac is a highly effective NSAID used for treating postoperative ocular inflammation and pain after cataract surgery and its advantage

February 10, 2023 Drug delivery / Pharma applications

Oral Xenon/alpha-Cyclodextrin Provides Neuroprotection for Ischemic Stroke

Ischemic stroke is one of the main causes of long-term morbidity/mortality and early treatment of stroke is key issue. Xenon

December 1, 2022 CD as API / Pharma applications

Cyclodextrins: Only Pharmaceutical Excipients or Full-Fledged Drug Candidates?

In this review, based on 250 references, the general chemical principles of direct cyclodextrin–protein interactions are summarized and highlighted, through